418 related articles for article (PubMed ID: 24121233)
1. Synthesis and antiproliferative activity of benzofuran-based analogs of cercosporamide against non-small cell lung cancer cell lines.
Bazin MA; Bodero L; Tomasoni C; Rousseau B; Roussakis C; Marchand P
Eur J Med Chem; 2013 Nov; 69():823-32. PubMed ID: 24121233
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, antiproliferative activities and in vitro biological evaluation of novel benzofuransulfonamide derivatives.
Yang L; Lei H; Mi CG; Liu H; Zhou T; Zhao YL; Lai XY; Li ZC; Song H; Huang WC
Bioorg Med Chem Lett; 2011 Sep; 21(18):5389-92. PubMed ID: 21795045
[TBL] [Abstract][Full Text] [Related]
3. Development of 3-methyl/3-(morpholinomethyl)benzofuran derivatives as novel antitumor agents towards non-small cell lung cancer cells.
Al-Sanea MM; Al-Ansary GH; Elsayed ZM; Maklad RM; Elkaeed EB; Abdelgawad MA; Bukhari SNA; Abdel-Aziz MM; Suliman H; Eldehna WM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):987-999. PubMed ID: 33985397
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and cytotoxic activity against a non-small-cell bronchopulmonary carcinoma line (NSCLC-N6) of benzofuran enantiomeric derivatives.
Hélesbeux JJ; Duval O; Séraphin D; Roussakis C; Richomme P
J Enzyme Inhib Med Chem; 2003 Apr; 18(2):159-65. PubMed ID: 12943200
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative potency of novel benzofuran-2-carboxamides on tumour cell lines: cell death mechanisms and determination of crystal structure.
Hranjec M; Sović I; Ratkaj I; Pavlović G; Ilić N; Valjalo L; Pavelić K; Kraljević Pavelić S; Karminski-Zamola G
Eur J Med Chem; 2013 Jan; 59():111-9. PubMed ID: 23220640
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of some novel benzofuran-2-yl(4,5-dihyro-3,5-substituted diphenylpyrazol-1-yl) methanones and studies on the antiproliferative effects and reversal of multidrug resistance of human MDR1-gene transfected mouse lymphoma cells in vitro.
Parekh S; Bhavsar D; Savant M; Thakrar S; Bavishi A; Parmar M; Vala H; Radadiya A; Pandya N; Serly J; Molnár J; Shah A
Eur J Med Chem; 2011 May; 46(5):1942-8. PubMed ID: 21396744
[TBL] [Abstract][Full Text] [Related]
7. Benzofuran derivatives as anticancer inhibitors of mTOR signaling.
Salomé C; Ribeiro N; Chavagnan T; Thuaud F; Serova M; de Gramont A; Faivre S; Raymond E; Désaubry L
Eur J Med Chem; 2014 Jun; 81():181-91. PubMed ID: 24836070
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-cancer activity evaluation of new aurone derivatives.
Demirayak S; Yurttas L; Gundogdu-Karaburun N; Karaburun AC; Kayagil I
J Enzyme Inhib Med Chem; 2015; 30(5):816-25. PubMed ID: 25716125
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents.
Wang XQ; Liu LX; Li Y; Sun CJ; Chen W; Li L; Zhang HB; Yang XD
Eur J Med Chem; 2013 Apr; 62():111-21. PubMed ID: 23353748
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines.
Cheng H; Zhang L; Liu Y; Chen S; Cheng H; Lu X; Zheng Z; Zhou GC
Eur J Med Chem; 2010 Dec; 45(12):5950-7. PubMed ID: 20974505
[TBL] [Abstract][Full Text] [Related]
11. 2,6-Disubstituted imidazo[2,1-b][1,3,4]thiadiazoles: search for anticancer agents.
Noolvi MN; Patel HM; Kamboj S; Kaur A; Mann V
Eur J Med Chem; 2012 Oct; 56():56-69. PubMed ID: 22960694
[TBL] [Abstract][Full Text] [Related]
12. Ethylenediamine diacetate (EDDA) mediated synthesis of aurones under ultrasound: their evaluation as inhibitors of SIRT1.
Manjulatha K; Srinivas S; Mulakayala N; Rambabu D; Prabhakar M; Arunasree KM; Alvala M; Basaveswara Rao MV; Pal M
Bioorg Med Chem Lett; 2012 Oct; 22(19):6160-5. PubMed ID: 22929231
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, biological evaluation and molecular docking studies of novel benzofuran-pyrazole derivatives as anticancer agents.
Abd El-Karim SS; Anwar MM; Mohamed NA; Nasr T; Elseginy SA
Bioorg Chem; 2015 Dec; 63():1-12. PubMed ID: 26368040
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo therapeutic efficacy of CXCR4 antagonist BKT140 against human non-small cell lung cancer.
Fahham D; Weiss ID; Abraham M; Beider K; Hanna W; Shlomai Z; Eizenberg O; Zamir G; Izhar U; Shapira OM; Peled A; Wald O
J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1167-1175.e1. PubMed ID: 22925564
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Novel Benzofuran Derivatives Bearing N-Aryl Piperazine Moiety.
Ma Y; Zheng X; Gao H; Wan C; Rao G; Mao Z
Molecules; 2016 Dec; 21(12):. PubMed ID: 27941680
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and anticancer activity of novel hybrid compounds between benzofuran and N-aryl piperazine.
Mao ZW; Zheng X; Lin YP; Hu CY; Wang XL; Wan CP; Rao GX
Bioorg Med Chem Lett; 2016 Aug; 26(15):3421-4. PubMed ID: 27371110
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
[TBL] [Abstract][Full Text] [Related]
19. HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues.
Xia Y; Jin Y; Kaur N; Choi Y; Lee K
Eur J Med Chem; 2011 Jun; 46(6):2386-96. PubMed ID: 21481991
[TBL] [Abstract][Full Text] [Related]
20. Discovery of hybrid Hsp90 inhibitors and their anti-neoplastic effects against gefitinib-resistant non-small cell lung cancer (NSCLC).
Jeong CH; Park HB; Jang WJ; Jung SH; Seo YH
Bioorg Med Chem Lett; 2014 Jan; 24(1):224-7. PubMed ID: 24345447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
